Evidence map›Paper›PMID 39497201›Full record

ArticleJournal of cheminformatics2024

Accurate prediction of protein-ligand interactions by combining physical energy functions and graph-neural networks.

Yiyu Hong, Junsu Ha, Jaemin Sim, Chae Jo Lim, Kwang-Seok Oh, Ramakrishnan Chandrasekaran, Bomin Kim, Jieun Choi, Junsu Ko, Woong-Hee Shin and 1 more

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Fragment-based drug discovery: A graphical review.Current research in pharmacology and drug discovery · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yiyu HongArontier Co., 241, Gangnam-daero, Seocho-gu, Seoul, 06735, Republic of Korea.
Junsu HaArontier Co., 241, Gangnam-daero, Seocho-gu, Seoul, 06735, Republic of Korea.
Jaemin SimDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, Republic of Korea.
Chae Jo LimData Convergence Drug Research Center, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
Kwang-Seok OhData Convergence Drug Research Center, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
Ramakrishnan ChandrasekaranArontier Co., 241, Gangnam-daero, Seocho-gu, Seoul, 06735, Republic of Korea.
Bomin KimCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Jieun ChoiCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Junsu KoArontier Co., 241, Gangnam-daero, Seocho-gu, Seoul, 06735, Republic of Korea. junsuko@arontier.co.
Woong-Hee ShinArontier Co., 241, Gangnam-daero, Seocho-gu, Seoul, 06735, Republic of Korea. whshin@korea.ac.kr.
Juyong LeeArontier Co., 241, Gangnam-daero, Seocho-gu, Seoul, 06735, Republic of Korea. nicole23@snu.ac.kr.

Funding

Korea Environmental Industry and Technology Institute RS-2023-00219144National Research Foundation of Korea NRF-2020M3A9G7103933
6 · The paper itself

Abstract

We introduce an advanced model for predicting protein-ligand interactions. Our approach combines the strengths of graph neural networks with physics-based scoring methods. Existing structure-based machine-learning models for protein-ligand binding prediction often fall short in practical virtual screening scenarios, hindered by the intricacies of binding poses, the chemical diversity of drug-like molecules, and the scarcity of crystallographic data for protein-ligand complexes. To overcome the limitations of existing machine learning-based prediction models, we propose a novel approach that fuses three independent neural network models. One classification model is designed to perform binary prediction of a given protein-ligand complex pose. The other two regression models are trained to predict the binding affinity and root-mean-square deviation of a ligand conformation from an input complex structure. We trained the model to account for both deviations in experimental and predicted binding affinities and pose prediction uncertainties. By effectively integrating the outputs of the triplet neural networks with a physics-based scoring function, our model showed a significantly improved performance in hit identification. The benchmark results with three independent decoy sets demonstrate that our model outperformed existing models in forward screening. Our model achieved top 1% enrichment factors of 32.7 and 23.1 with the CASF2016 and DUD-E benchmark sets, respectively. The benchmark results using the LIT-PCBA set further confirmed its higher average enrichment factors, emphasizing the model's efficiency and generalizability. The model's efficiency was further validated by identifying 23 active compounds from 63 candidates in experimental screening for autotaxin inhibitors, demonstrating its practical applicability in hit discovery.Scientific contributionOur work introduces a novel training strategy for a protein-ligand binding affinity prediction model by integrating the outputs of three independent sub-models and utilizing expertly crafted decoy sets. The model showcases exceptional performance across multiple benchmarks. The high enrichment factors in the LIT-PCBA benchmark demonstrate its potential to accelerate hit discovery.

Indexed as

Deep-learningGraph neural networkHit discoveryPhysics-based scoring functionProtein–ligand binding pose predictionProtein–ligand binding predictionProtein–ligand dockingVirtual screening

Identifiers

PMID39497201
PMCPMC11536843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.